Wells Fargo
HRMY icon

Wells Fargo’s Harmony Biosciences HRMY Stock Holding History

Wells Fargo’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
44,381
+26,347
+146% +$831K ﹤0.01% 3770
2026
Q1 		$505K Sell
18,034
-31,338
-63% -$1.03M ﹤0.01% 4163
2025
Q4 		$1.85M Sell
49,372
-65,894
-57% -$2.17M ﹤0.01% 3511
2025
Q3 		$3.18M Buy
115,266
+5,150
+5% +$177K ﹤0.01% 2963
2025
Q2 		$3.48M Buy
110,116
+6,336
+6% +$204K ﹤0.01% 2746
2025
Q1 		$3.44M Buy
103,780
+85,775
+476% +$3.07M ﹤0.01% 2711
2024
Q4 		$620K Sell
18,005
-95,490
-84% -$3.28M ﹤0.01% 4038
2024
Q3 		$4.54M Buy
113,495
+96,727
+577% +$3.4M ﹤0.01% 2415
2024
Q2 		$506K Buy
16,768
+23
+0.1% +$692 ﹤0.01% 3907
2024
Q1 		$562K Buy
16,745
+1,267
+8% +$40.7K ﹤0.01% 3814
2023
Q4 		$500K Buy
15,478
+543
+4% +$15.2K ﹤0.01% 3873
2023
Q3 		$489K Sell
14,935
-26,999
-64% -$937K ﹤0.01% 3799
2023
Q2 		$1.48M Buy
41,934
+7,262
+21% +$251K ﹤0.01% 3152
2023
Q1 		$1.13M Buy
34,672
+9,831
+40% +$448K ﹤0.01% 3287
2022
Q4 		$1.37M Buy
24,841
+14,446
+139% +$794K ﹤0.01% 3047
2022
Q3 		$460K Sell
10,395
-4,307
-29% -$210K ﹤0.01% 3735
2022
Q2 		$717K Sell
14,702
-2,289
-13% -$103K ﹤0.01% 3512
2022
Q1 		$827K Sell
16,991
-7,478
-31% -$305K ﹤0.01% 4052
2021
Q4 		$1.04M Sell
24,469
-57,675
-70% -$2.3M ﹤0.01% 4065
2021
Q3 		$3.15M Buy
82,144
+72,383
+742% +$2.33M ﹤0.01% 3271
2021
Q2 		$276K Buy
9,761
+2,857
+41% +$85.7K ﹤0.01% 4894
2021
Q1 		$228K Sell
6,904
-26,312
-79% -$923K ﹤0.01% 5093
2020
Q4 		$1.2M Buy
33,216
+32,216
+3,222% +$1.3M ﹤0.01% 3893
2020
Q3 		$34K Buy
+1,000
New +$36.5K ﹤0.01% 5631

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo's HRMY Position: Q2 2026 in Review

Wells Fargo increased its Harmony Biosciences (HRMY) stake by 146% in Q2 2026, buying an estimated $831K and bringing the position to 44,381 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Wells Fargo first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.54M in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Wells Fargo held 44,381 shares of Harmony Biosciences worth $1.62M as of Q2 2026.
  • Wells Fargo bought 26,347 Harmony Biosciences shares in Q2 2026, an estimated $831K.
  • Harmony Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3770 holding.
  • Wells Fargo first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Wells Fargo's Harmony Biosciences position peaked at $4.54M in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.